ENT Devices Market (By Product: Diagnostic ENT Devices, Surgical ENT Devices, Hearing Aids, Hearing Implants, and Nasal Splints; By End User: Hospitals, Clinics, Ambulatory Settings, & others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2021 – 2030


The global ENT devices market was valued at USD 21.5 billion in 2021 and expected to hit USD 30.5 billion by 2030, poised to grow at a compound annual growth rate (CAGR) of 5% during the forecast period 2021 to 2030.

ENT Devices Market Size 2021 to 2030

Growth Factors

The abbreviation ENT stands for ear, nose, and throat, and ENT devices refers to the instruments that deal with these organs. These devices are used by doctors to treat medical conditions related to ear, nose, and throat.

A wide range of ENT devices are available in the market that are designed for dealing with problems in the structures of the head and neck such as the ear, nose and throat. Some of the major instruments used are Aural Forceps, Nasal Forceps, Tongue Depressors, Speculums, and Laryngoscopes. Demand for these devices is rising as they eases the process of treatment and convenience. Moreover, the growing prevalence of ear, nose, and throat problems among adults is a primary factor driving global demand for ENT equipment. Ear, nose, and throat disorders have a substantial negative impact on one's quality of life and are the most common reason for frequent hospital visits. Furthermore, as the elderly population grows, the frequency of hospital visits connected to ENT disorders continues to climb and hence, the industry is rising.

The ENT surgical devices and equipment uses is being driven by rising demand and adoption of minimally invasive ENT surgeries. Patients benefit from minimally invasive ENT operations because they have smaller incisions, faster recovery times, less pain, and less scarring.

The market for these devices is being boosted greatly by the fast-increasing biotechnology and healthcare industries in developed nations such as U.S. and Canada. However, the ENT device market is hampered by the high cost of ENT devices and procedures, as well as the high cost of equipment. The high cost of ENT operations, which is related to increased research and development expenditures as well as other constant and variable costs connected with medical equipment, is a major stumbling block.

As the healthcare industry is one of the highest growing industries across globe, the diseases and disorders related to ENT will also boost, hence the demand for these devices will boost.

Scope of the ENT Devices Market Report

Report Highlights Details
Market Size USD 30.5 Billion by 2030
Growth Rate CAGR of 5% From 2021 to 2030
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Product, End User, Region
Companies Mentioned Demant A/S, Sonova, Ambu A/S, Pentax Medical, Karl Storz, Olympus Corporation, Richard Wolf Gmbh, Widex, Cochlear Ltd., Sivantos, Inc.

 

Product Insights:

Based on product, the Diagnostic ENT Devices segment dominated the market 29% in 2020, in terms of revenue and is expected to sustain its dominance during the forecast period. This is attributable to the introduction of new technologies and availability of several products in the market.

ENT Devices Market Share, By Product, 2020 (%)

The hearing aids segment is expected to grow at the noteworthy CAGR during the forecast period due to an increase in investment on R&D by market players.

End User Insights

Based on end user, the hospitals segment dominated the global ENT Devices market in 2020, in terms of revenue and is estimated to sustain its dominance during the forecast period. The factors augment the growth of the segment are increasing demand for hearing care devices and presence of large hospitals chains.

The clinics segment is expected to be the fastest-growing segment during the forecast period. This is attributed to the advancements in clinical diagnostic methods and increasing awareness about diagnosis and treatment of the disease.

Region Insights

Based on region, North America dominated the global ENT Devices market in 2020, in terms of revenue and is estimated to sustain its dominance during the forecast period. Presence of developed healthcare infrastructure, increased health consciousness, rising healthcare expenditure, and rapidly surging popularity of the minimal invasive surgeries are the several crucial factors that spur the demand for the ENT devices in North America.

ENT Devices Market Share, By Region, 2020 (%)

On the Other hand, Asia Pacific is expected to be the fastest-growing market during the forecast period. The growing prevalence of ear, nose, and throat related disorders among the old age population is fueling the demand for the ENT devices. According to the World Health Organization, the proportion of the global population of over 60 years is anticipated to double from 12% to 22%, between 2015 and 2050. Around 80% of the global geriatric population will be living in low and middle-income nations. Hence, Asia Pacific is estimated to be the fastest-growing market in the forthcoming years.

Key Companies & Market Share Insights

The market is moderately fragmented with the presence of several local companies. These market players are striving to gain higher market share by adopting strategies, such as investments, partnerships, and acquisitions & mergers. Companies are also spending on the development of improved products. Moreover, they are also focusing on maintaining competitive pricing.

In September 2019, Cochlear Limited and GN Hearing collaborated with google for direct streaming android devices to hearing using Bluetooth Low Energy (BLE).

In September 2020, WS Audiology is a privately-owned manufacturer of hearing aids, launched of WIDEX MOMENT-the first generation of hearing aids that sound natural.

The various developmental strategies like acquisitions and mergers foster market growth and offers lucrative growth opportunities to the market players.

Some of the prominent players in the global ENT Devices market include:

  • Demant A/S
  • Sonova
  • Ambu A/S
  • Pentax Medical
  • Karl Storz
  • Olympus Corporation
  • Richard Wolf Gmbh
  • Widex
  • Cochlear Ltd.
  • Sivantos, Inc.

Segments Covered in the Report

By Product

  • Diagnostic ENT Devices
  • Surgical ENT Devices
  • Hearing Aids
  • Hearing Implants
  • Nasal Splints

By End User

  • Hospitals
  • Ambulatory settings
  • ENT clinics
  • Research and academic institutes
  • Others

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Rest of the World

Frequently Asked Questions

What is the current size of ENT devices market?
According to Precedence Research, the global ENT devices market size was reached at USD 21.5 billion in 2021 and is predicted to reach USD 30.5 billion by 2030.
The global ENT devices market is expected to grow at a CAGR of 5% during the forecast period 2021 to 2030.
The factors which spurs the growth of the market are rising geriatric population, increasing prevalence of ENT-related disorders, increasing penetration of minimally invasive ENT procedures.
The major players operating in the ENT devices market are Demant A/S, Sonova, Ambu A/S, Pentax Medical, Karl Storz, Olympus Corporation, Richard Wolf Gmbh, Widex, Cochlear Ltd., Sivantos, Inc..
North America dominated the market in 2020 and will lead over the forecast period.

PROCEED TO BUY

   USD 4500
   USD 7000
   USD 9000

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample